Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6

被引:184
|
作者
Fiesel, Fabienne C. [1 ]
Voigt, Aaron [1 ,2 ]
Weber, Stephanie S.
Van den Haute, Chris [3 ]
Waldenmaier, Andrea [4 ]
Goerner, Karin [4 ]
Walter, Michael [5 ]
Anderson, Marlene L. [1 ]
Kern, Jeannine V. [6 ]
Rasse, Tobias M. [6 ]
Schmidt, Thorsten [7 ]
Springer, Wolfdieter [1 ]
Kirchner, Roland [4 ]
Bonin, Michael [5 ]
Neumann, Manuela [8 ]
Baekelandt, Veerle [3 ]
Alunni-Fabbroni, Marianna [4 ]
Schulz, Joerg B. [2 ]
Kahle, Philipp J. [1 ]
机构
[1] Univ Clin Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Lab Funct Neurogenet, D-72076 Tubingen, Germany
[2] Rhein Westfal TH Aachen, Dept Neurol, Univ Med Ctr, D-5100 Aachen, Germany
[3] Katholieke Univ Leuven, Dept Mol & Cellular Med, Div Mol Med, Lab Neurobiol & Gene Therapy, Louvain, Belgium
[4] Beckman Coulter Biomed GmbH, Munich, Germany
[5] Univ Tubingen, Microarray Facil, Tubingen, Germany
[6] Hertie Inst Clin Brain Res, Synapt Plast Grp, Tubingen, Germany
[7] Univ Tubingen, Dept Med Genet, Tubingen, Germany
[8] Univ Zurich, Inst Neuropathol, Zurich, Switzerland
来源
EMBO JOURNAL | 2010年 / 29卷 / 01期
关键词
frontotemporal dementia; HDAC6; microarray; motoneuron disease; TDP-43; FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; VALOSIN-CONTAINING PROTEIN; NUCLEAR FACTOR TDP-43; MOTOR-NEURON DISEASE; IN-VIVO; FUNCTIONAL IMPLICATIONS; AGGRESOME FORMATION; ACID BINDING; CFTR EXON-9;
D O I
10.1038/emboj.2009.324
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TDP-43 is an RNA/DNA-binding protein implicated in transcriptional repression and mRNA processing. Inclusions of TDP-43 are hallmarks of frontotemporal dementia and amyotrophic lateral sclerosis. Besides aggregation of TDP-43, loss of nuclear localization is observed in disease. To identify relevant targets of TDP-43, we performed expression profiling. Thereby, histone deacetylase 6 (HDAC6) downregulation was discovered on TDP-43 silencing and confirmed at the mRNA and protein level in human embryonic kidney HEK293E and neuronal SH-SY5Y cells. This was accompanied by accumulation of the major HDAC6 substrate, acetyl-tubulin. HDAC6 levels were restored by re-expression of TDP-43, dependent on RNA binding and the C-terminal protein interaction domains. Moreover, TDP-43 bound specifically to HDAC6 mRNA arguing for a direct functional interaction. Importantly, in vivo validation in TDP-43 knockout Drosophila melanogaster confirmed the specific downregulation of HDAC6. HDAC6 is necessary for protein aggregate formation and degradation. Indeed, HDAC6-dependent reduction of cellular aggregate formation and increased cytotoxicity of polyQ-expanded ataxin-3 were found in TDP-43 silenced cells. In conclusion, loss of functional TDP-43 causes HDAC6 downregulation and might thereby contribute to pathogenesis. The EMBO Journal (2010) 29, 209-221. doi: 10.1038/emboj.2009.324; Published online 12 November 2009
引用
收藏
页码:209 / 221
页数:13
相关论文
共 50 条
  • [31] Review: Prion-like mechanisms of transactive response DNA binding protein of 43kDa (TDP-43) in amyotrophic lateral sclerosis (ALS)
    Smethurst, P.
    Sidle, K. C. L.
    Hardy, J.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2015, 41 (05) : 578 - 597
  • [32] AN ALS MOUSE MODEL WITH LOSS-OF-FUNCTION OF THE RNA/DNA-BINDING PROTEIN TDP-43
    Shen, C. -K.
    Wu, L. -S.
    Cheng, W. -C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 224 - 224
  • [33] Enteroviral Infection Leads to Transactive Response DNA-Binding Protein 43 Pathology in Vivo
    Xue, Yuan Chao
    Ruller, Chelsea M.
    Fung, Gabriel
    Mohamud, Yasir
    Deng, Haoyu
    Liu, Huitao
    Zhang, Jingchun
    Feuer, Ralph
    Luo, Honglin
    AMERICAN JOURNAL OF PATHOLOGY, 2018, 188 (12): : 2853 - 2862
  • [34] Transactive Response DNA-Binding Protein 43 Abnormalities after Traumatic Brain Injury
    Tan, Xin Lin
    Sun, Mujun
    Brady, Rhys D.
    Liu, Shijie
    Llanos, Roxana
    Cheung, Steve
    Wright, David K.
    Casillas-Espinosa, Pablo M.
    Sashindranath, Maithili
    O'Brien, Terence J.
    McDonald, Stuart J.
    Turner, Bradley J.
    Shultz, Sandy R.
    JOURNAL OF NEUROTRAUMA, 2019, 36 (01) : 87 - 99
  • [35] TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic target
    Al Ojaimi, Yara
    Dangoumau, Audrey
    Alarcan, Hugo
    Hergesheimer, Rudolf
    Vourc'h, Patrick
    Corcia, Philippe
    Lanznaster, Debora
    Blasco, Helene
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (06) : 575 - 592
  • [36] Detection of TAR DNA-Binding Protein 43 (TDP-43) Oligomers as Initial Intermediates Species during Aggregate Formation
    French, Rachel L.
    Grese, Zachary R.
    Dhavale, Dhruva D.
    Reed, Ashley N.
    Kedia, Niraja
    Kotzbauer, Paul T.
    Bieschke, Jan
    Ayala, Yuna M.
    ANNALS OF NEUROLOGY, 2019, 86 : S58 - S58
  • [37] Biophysical characterization of full-length TAR DNA-binding protein (TDP-43) phase separation
    Staderini, Tommaso
    Bigi, Alessandra
    Mongiello, Daniele
    Cecchi, Cristina
    Chiti, Fabrizio
    PROTEIN SCIENCE, 2022, 31 (12)
  • [38] Requirements for Stress Granule Recruitment of Fused in Sarcoma (FUS) and TAR DNA-binding Protein of 43 kDa (TDP-43)
    Bentmann, Eva
    Neumann, M.
    Tahirovic, S.
    Rodde, R.
    Dormann, D.
    Haass, C.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 59 - +
  • [39] Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43
    Yvonne Davidson
    Thomas Kelley
    Ian R. A. Mackenzie
    Stuart Pickering-Brown
    Daniel Du Plessis
    David Neary
    Julie S. Snowden
    David M. A. Mann
    Acta Neuropathologica, 2007, 113 : 521 - 533
  • [40] Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation
    French, Rachel L.
    Grese, Zachary R.
    Aligireddy, Himani
    Dhavale, Dhruva D.
    Reeb, Ashley N.
    Kedia, Niraja
    Kotzbauer, Paul T.
    Bieschke, Jan
    Ayala, Yuna M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (17) : 6696 - 6709